首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR TREATING OXIDATIVE STRESS-INDUCED PATHOLOGY AND USE THEREOF

PHARMACEUTICAL COMPOSITION FOR TREATING OXIDATIVE STRESS-INDUCED PATHOLOGY AND USE THEREOF

机译:用于治疗氧化应激性病理的药物组合物及其用途

摘要

Pharmaceutical composition for treating oxidative stress induced pathology, comprising an association of the active ingredients methionine, cysteine and phenylalanine in association with at least one pharmaceutical excipient; said active ingredients being present in a methionine/phenylalanine molar ratio between 2.5 and 12.5; and in a methionine/cysteine molar ratio between 2 and 10.5; and the three active ingredients being present in free state, such as inner salt, or in the form of pharmaceutically acceptable sa wherein said pharmaceutical composition is used for treating one of the oxidative stress induced pathologies, including intestinal system disorders, such as intestinal wall irritations, hemorrhoids of types 1, 2, 3 and 4 of Goligher classification. It is also disclosed the use of said composition in preparing a medication for treating oxidative stress induced pathology.
机译:用于治疗氧化应激诱导的病理的药物组合物,其包含活性成分蛋氨酸,半胱氨酸和苯丙氨酸与至少一种药物赋形剂的缔合;所述活性成分的蛋氨酸/苯丙氨酸摩尔比为2.5至12.5。甲硫氨酸/半胱氨酸的摩尔比为2至10.5;三种活性成分以游离态存在,例如内盐或以药学上可接受的盐形式存在;其中所述药物组合物用于治疗氧化应激诱导的病理学之一,包括肠系统疾病,例如肠壁刺激,Goligher分类的1、2、3和4型痔疮。还公开了所述组合物在制备用于治疗氧化应激诱导的病理的药物中的用途。

著录项

  • 公开/公告号US2014005268A1

    专利类型

  • 公开/公告日2014-01-02

    原文格式PDF

  • 申请/专利权人 EDUARDO MOTTA ALVES PEIXOTO;

    申请/专利号US201213980606

  • 发明设计人 EDUARDO MOTTA ALVES PEIXOTO;

    申请日2012-01-18

  • 分类号A61K31/198;

  • 国家 US

  • 入库时间 2022-08-21 16:02:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号